Drug Profile
Research programme: plasminogen activator inhibitor 1 inhibitors - Groupe Fournier
Alternative Names: Plasminogen activator inhibitor 1 inhibitors research programme - Groupe FournierLatest Information Update: 30 Mar 2001
Price :
$50
*
At a glance
- Originator Groupe Fournier
- Class
- Mechanism of Action Plasminogen activator inhibitor-1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 30 Mar 2001 Discontinued-Preclinical for Thrombosis in France (Unknown route)
- 23 Dec 1999 Plasminogen activator inhibitor 1 inhibitors are available for licensing (http://www.groupe-fournier.com/english/)
- 16 Dec 1999 Preclinical development for Thrombosis in France (Unknown route)